Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAF |
| Upstream (Parents) |
|---|
| (<<) ETV4 → MAF |
| (<<) AR → MAF |
| (<<) NR5A2 → MAF |
| (<<) CEBPD → MAF |
| (<<) NR3C1 → MAF |
| (<<) MYC → MAF |
| (<<) ELF3 → MAF |
| (<<) STAT1 → MAF |
| (<<) E2F1 → MAF |
| (<<) CITED2 → MAF |
| Downstream (Children) |
|---|
| MAF → TEF (>>) |
| MAF → NPAS2 (>>) |
| MAF → FOXJ1 (>>) |
| MAF → TSHZ2 (>>) |
| MAF → POU6F2 (>>) |
| MAF → IRX4 (>>) |
| MAF → T (>>) |
| MAF → MSX1 (>>) |
| MAF → DLX4 (>>) |
| MAF → GBX2 (>>) |
| MAF → CBFA2T3 (>>) |
| MAF → ETV3 (>>) |
| MAF → ZNF83 (>>) |
| MAF → HOXC13 (>>) |
